Literature DB >> 22412233

Direct tissue evaluation via immunofluorescence: in the diagnosis of hereditary transthyretin cardiac amyloidosis.

Michael G Fradley1, Joseph V Thakuria, A Bernard Collins, Stephanie A Moore, James R Stone.   

Abstract

Multiple precursor proteins have been shown to cause cardiac amyloidosis. The most common forms are due either to immunoglobulin light chains or to transthyretin proteins (either wild-type or mutant forms). Correct subclassification of the amyloid is paramount because treatment differs in accordance with the type of amyloidosis. Indirect diagnostic methods, including serologic analysis, can lead to misdiagnosis. Definitive diagnosis often requires analysis of amyloid in the tissue. We present a case of a woman who was diagnosed with hereditary transthyretin cardiac amyloidosis by means of immunofluorescence and genetic analysis. This case highlights the importance-in the diagnostic algorithm of cardiac amyloidosis-of direct evaluation of the tissue with immunofluorescence and of genetic testing.

Entities:  

Keywords:  Amyloid neuropathies, familial/genetics; amyloidosis, cardiac/classification/diagnosis/physiopathology/therapy; diagnostic errors/prevention & control; diflunisal; fluorescent antibody technique; immunoenzyme techniques; polyneuropathies; transthyretin-related amyloid fibril protein, human

Mesh:

Substances:

Year:  2012        PMID: 22412233      PMCID: PMC3298917     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  16 in total

1.  Amyloid in endomyocardial biopsies.

Authors:  Barbara Kieninger; Magdalena Eriksson; Reinhard Kandolf; Philipp A Schnabel; Stefan Schönland; Arnt V Kristen; Ute Hegenbart; Peter Lohse; Christoph Röcken
Journal:  Virchows Arch       Date:  2010-04-08       Impact factor: 4.064

2.  Cardiovascular magnetic resonance in cardiac amyloidosis.

Authors:  Alicia Maria Maceira; Jayshree Joshi; Sanjay Kumar Prasad; James Charles Moon; Enrica Perugini; Idris Harding; Mary Noelle Sheppard; Philip Alexander Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Journal:  Circulation       Date:  2005-01-03       Impact factor: 29.690

3.  Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis.

Authors:  Yoshiki Sekijima; Maria A Dendle; Jeffery W Kelly
Journal:  Amyloid       Date:  2006-12       Impact factor: 7.141

Review 4.  Transthyretin mutations in hyperthyroxinemia and amyloid diseases.

Authors:  M J Saraiva
Journal:  Hum Mutat       Date:  2001-06       Impact factor: 4.878

5.  Chemical typing of amyloid protein contained in formalin-fixed paraffin-embedded biopsy specimens.

Authors:  C L Murphy; M Eulitz; R Hrncic; K Sletten; P Westermark; T Williams; S D Macy; C Wooliver; J Wall; D T Weiss; A Solomon
Journal:  Am J Clin Pathol       Date:  2001-07       Impact factor: 2.493

6.  Diagnosis and immunohistochemical classification of systemic amyloidoses. Report of 43 cases in an unselected autopsy series.

Authors:  R J Strege; W Saeger; R P Linke
Journal:  Virchows Arch       Date:  1998-07       Impact factor: 4.064

7.  Classification of amyloid deposits in diagnostic cardiac specimens by immunofluorescence.

Authors:  A Bernard Collins; R Neal Smith; James R Stone
Journal:  Cardiovasc Pathol       Date:  2008-07-11       Impact factor: 2.185

8.  Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis.

Authors:  Helen J Lachmann; David R Booth; Susanne E Booth; Alison Bybee; Janet A Gilbertson; Julian D Gillmore; Mark B Pepys; Philip N Hawkins
Journal:  N Engl J Med       Date:  2002-06-06       Impact factor: 91.245

9.  Tabulation of human transthyretin (TTR) variants, 2003.

Authors:  Lawreen Heller Connors; Amareth Lim; Tatiana Prokaeva; Violet A Roskens; Catherine E Costello
Journal:  Amyloid       Date:  2003-09       Impact factor: 7.141

10.  Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy.

Authors:  Takeshi Hattori; Yo-ichi Takei; Jun Koyama; Masamitsu Nakazato; Shu-ichi Ikeda
Journal:  Amyloid       Date:  2003-12       Impact factor: 7.141

View more
  1 in total

1.  Heavy and light chain (AHL)-type cardiac amyloidosis: first histopathologic-proven case illustrating involvement of the heart.

Authors:  Miroslav Sekulic; Simona Pichler Sekulic; Astrid Weins
Journal:  Virchows Arch       Date:  2020-05-09       Impact factor: 4.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.